Trial register facet
Trial records in obesity and overweight in adults — page 9
208 records bearing on obesity and overweight in adults.
Showing 0 records on this page
Records
208 documents · page 9 of 9
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| SYNCHRONIZE-1-OLEprogramme record | Survodutide | Phase 3 | Ongoing | Single-arm open-label | — | — | Very low |
| SYNCHRONIZE-CVOT-PKprogramme record | Survodutide | Phase 1 | Ongoing | Phase 1 ascending dose | — | — | Very low |
| DREAMS-3-REGIONAL-JPprogramme record | Mazdutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| PETRE-PH2-OBESITY-BODY-COMPprogramme record | Petrelintide | Phase 2 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| TRIUMPH-1-DDIprogramme record | Retatrutide | Phase 1 | Ongoing | Randomised crossover | — | — | Very low |
| TRIUMPH-2-BODY-COMPprogramme record | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| TRIUMPH-3-BIOMARKERprogramme record | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| REDEFINE-4-DDIprogramme record | CagriSema (cagrilintide with semaglutide) | Phase 1 | Ongoing | Randomised crossover | — | — | Very low |
| SYNCHRONIZE-1-ADHERENCEprogramme record | Survodutide | Phase 3 | Ongoing | Observational | — | — | Very low |
| DREAMS-3-REGIONAL-CNprogramme record | Mazdutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| PETRE-PH2-OBESITY-QOLprogramme record | Petrelintide | Phase 2 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| TRIUMPH-2-REGIONAL-JPprogramme record | Retatrutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SYNCHRONIZE-1-BIOMARKERprogramme record | Survodutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| SYNCHRONIZE-2-REGIONAL-CNprogramme record | Survodutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
| MARITIDE-PH3-HEPATIC-IMPprogramme record | Maridebart cafraglutide | Phase 1 | Ongoing | Phase 1 ascending dose | — | — | Very low |
| MARITIDE-PH3-BIOMARKERprogramme record | Maridebart cafraglutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |
page 9 of 9